NFE2L2 and nodular goiter: A recent study by Geng et al. (2017) indicates that the Nrf2 pathway is commonly activated in PTC and occasionally is activated in benign thyroid lesions, suggesting that prolonged activation of NRF2 and its elevated expression may contribute to the occurrence of nodular goiter and PTC [22].